AACR Conference Coverage
Featured Articles
(Penn LDI) Apr 18, 2018 - Spending on cancer drugs in the United States has nearly doubled in the past five years and continues to grow, imposing substantial financial burden on patients with cancer. One of the biggest drivers of this growth is targeted cancer drugs.
Read Article
(BMS) Apr 16, 2018 - Patients treated with Opdivo experienced a 32% reduction in the risk of death after two years minimum follow-up; Opdivo remains the only PD-1 inhibitor to demonstrate statistically significant OS versus standard chemotherapy in the primary analysis of a Phase 3 trial in these patients, with benefit maintained with...
Read Article
Latest Articles
April 19, 2018
April 19, 2018
April 18, 2018
April 18, 2018
April 18, 2018
April 18, 2018
April 18, 2018
April 18, 2018
View More
News Commentary
There is no AACR Conference Coverage commentary.

OBR Green
There are no AACR Conference Coverage OBR Green articles.
Featured Videos
There are no videos.
OBR Blog
Facts first, then comments. Keynote -189: This phase III trial compared pembrolizumab (pembro), or placebo, plus... Read more
April 17, 2018
A pre-meeting webinar provided a glimpse of some of the key presentations at the upcoming annual meeting of the... Read more
March 16, 2018